Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 261–280 of 17,529 recalls

October 10, 2025· Endo USA, Inc.

Recalled Item: Everolimus tablets 7.5mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
October 10, 2025· Endo USA, Inc.

Recalled Item: Everolimus tablets 2.5 mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
October 10, 2025· QuVa Pharma, Inc.

Recalled Item: R.E.C.K. (Ropivacaine HCl

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 10, 2025· Endo USA, Inc.

Recalled Item: Everolimus tablets 10 mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
October 10, 2025· Endo USA, Inc.

Recalled Item: Everolimus tablets 5mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
October 10, 2025· Lannett Company Inc.

Recalled Item: Niacin Extended-release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 10, 2025· The Harvard Drug Group LLC

Recalled Item: Gabapentin Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 10, 2025· The Harvard Drug Group LLC

Recalled Item: Gabapentin Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 9, 2025· STAQ Pharma, Inc.

Recalled Item: Ketamine Hydrochloride

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
October 9, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 9, 2025· ibspot

Recalled Item: Taoscare Motion Sickness Patches 36-count box

The Issue: Marketed Without an Approved NDA/ANDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 9, 2025· USV Private Limited

Recalled Item: Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 9, 2025· Amerisource Health Services LLC

Recalled Item: Sucralfate Tablets

The Issue: CGMP Deviations: The recalling firm filed for Chapter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 9, 2025· STAQ Pharma, Inc.

Recalled Item: Hydromorphone HCL PF

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
October 9, 2025· STAQ Pharma, Inc.

Recalled Item: FentaNYL Citrate PF

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
October 8, 2025· Mohamed Hagar

Recalled Item: Mojo Max Fusion XXX

The Issue: Undeclared Sildenafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
October 8, 2025· ASTRAZENECA PHARMACEUTICALS

Recalled Item: Fasenra (benralizumab) Injection

The Issue: Lack of Assurance of Sterility:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 7, 2025· Teva Pharmaceuticals USA, Inc

Recalled Item: Prazosin Hydrochloride

The Issue: CGMP Deviations-Test results for N-nitroso Prazosin impurity C

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 7, 2025· Teva Pharmaceuticals USA, Inc

Recalled Item: Prazosin Hydrochloride

The Issue: CGMP Deviations-Test results for N-nitroso Prazosin impurity C

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 7, 2025· Teva Pharmaceuticals USA, Inc

Recalled Item: Prazosin Hydrochloride

The Issue: CGMP Deviations-Test results for N-nitroso Prazosin impurity C

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund